Global Veterinary Pain Management Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Veterinary pain management is a medical approach that is draws towards diagnosis, prevention, and treatment of pain among veterinary, which are caused by factors including surgical procedures, internal organ problems, slipped disc, arthritis, physical trauma, and joint damage. The growth in companion animal population, rising animal healthcare expenditure, and increasing number of veterinary practitioners in developed economies
The rising emphasis on animal healthcare is leveraging the growth of the global market. According to Statista, the global animal health market has significant increase with an estimated value of USD 28.9 billion from 2018 to 33.7 billion in 2021. Therefore, the growing expenditure on providing better healthcare services to animals is exhibiting a positive influence on market growth. Moreover, the high popularity of non-conventional and non-pharmaceutical treatment techniques and increasing technological advancements and innovation are creating growth prospects to the market in the impending years. However, rising pet care costs and stringent regulatory process are hindering stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Veterinary Pain Management Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the space in terms of revenue, owing to the increasing investment in animal healthcare facilities and rising presence of skilled professionals and leading market players. Whereas, Asia Pacific is expected to grow significantly during the forecast period. Factors such as rising prevalence of animal diseases, as well as increasing adoption of pets are burgeoning the market growth in the forecasting years.
Major market players included in this report are:
Boehringer Ingelheim International GmbH
Zoetis Inc.
Elanco Animal Health Incorporated
Merck & Co., Inc.
Dechra Pharmaceuticals
Vetoquinol
SeQuent Scientific Limited
Norbrook Laboratories Limited
Ceva Sante Animale
Chanelle Pharma
Recent Developments in the Market:
- In December 2018, Merck declared the acquisition of Antelliq with the objective of enhancing their animal vaccines and pharmaceutical portfolio.
- In January 2018, Elanco publicized that the company received European approval for its marketing and selling of the product Galliprant across the European region.
- In January 2018, Dechra Pharmaceuticals announced that the company acquired Le Vet and Ast Farma, which aims on to expanding its business operations across the Netherlands and Europe.
Global Veterinary Pain Management Market Report Scope:
Historical Data: 2019-2020-2021
Base Year for Estimation: 2021
Forecast period: 2022-2029
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Product, Indication, Animal Type, End User, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
NSAIDs
Anesthetics
Opioids
Others
By Indication:
Osteoarthritis
Post-operative pain
Others
By Animal Type:
Livestock Animal
Companion Animal
By End User:
Hospitals & Clinics
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
- 1.2.1. Veterinary Pain Management Market, by Region, 2019-2029 (USD Billion)
- 1.2.2. Veterinary Pain Management Market, by Product, 2019-2029 (USD Billion)
- 1.2.3. Veterinary Pain Management Market, by Indication, 2019-2029 (USD Billion)
- 1.2.4. Veterinary Pain Management Market, by Animal Type, 2019-2029 (USD Billion)
- 1.2.5. Veterinary Pain Management Market, by End User, 2019-2029 (USD Billion)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Veterinary Pain Management Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Veterinary Pain Management Market Dynamics
- 3.1. Veterinary Pain Management Market Impact Analysis (2019-2029)
- 3.1.1. Market Drivers
- 3.1.1.1. Growth in companion animal population
- 3.1.1.2. Rising animal healthcare expenditure
- 3.1.2. Market Challenges
- 3.1.2.1. Rising pet care costs
- 3.1.2.2. Stringent regulatory process
- 3.1.3. Market Opportunities
- 3.1.3.1. High popularity of non-conventional and non-pharmaceutical treatment techniques
- 3.1.3.2. Increasing technological advancements and innovation
Chapter 4. Global Veterinary Pain Management Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
- 4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.4. Investment Adoption Model
- 4.5. Analyst Recommendation & Conclusion
- 4.6. Top investment opportunity
- 4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
- 5.1. Assessment of the overall impact of COVID-19 on the industry
- 5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Veterinary Pain Management Market, by Product
- 6.1. Market Snapshot
- 6.2. Global Veterinary Pain Management Market by Product, Performance - Potential Analysis
- 6.3. Global Veterinary Pain Management Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
- 6.4. Veterinary Pain Management Market, Sub Segment Analysis
- 6.4.1. NSAIDs
- 6.4.2. Anesthetics
- 6.4.3. Opioids
- 6.4.4. Others
Chapter 7. Global Veterinary Pain Management Market, by Indication
- 7.1. Market Snapshot
- 7.2. Global Veterinary Pain Management Market by Indication, Performance - Potential Analysis
- 7.3. Global Veterinary Pain Management Market Estimates & Forecasts by Indication 2019-2029 (USD Billion)
- 7.4. Veterinary Pain Management Market, Sub Segment Analysis
- 7.4.1. Osteoarthritis
- 7.4.2. Post-operative pain
- 7.4.3. Others
Chapter 8. Global Veterinary Pain Management Market, by Animal Type
- 8.1. Market Snapshot
- 8.2. Global Veterinary Pain Management Market by Animal Type, Performance - Potential Analysis
- 8.3. Global Veterinary Pain Management Market Estimates & Forecasts by Animal Type 2019-2029 (USD Billion)
- 8.4. Veterinary Pain Management Market, Sub Segment Analysis
- 8.4.1. Livestock Animal
- 8.4.2. Companion Animal
Chapter 9. Global Veterinary Pain Management Market, by End User
- 9.1. Market Snapshot
- 9.2. Global Veterinary Pain Management Market by End User, Performance - Potential Analysis
- 9.3. Global Veterinary Pain Management Market Estimates & Forecasts by End User 2019-2029 (USD Billion)
- 9.4. Veterinary Pain Management Market, Sub Segment Analysis
- 9.4.1. Hospitals & Clinics
- 9.4.2. Others
Chapter 10. Global Veterinary Pain Management Market, Regional Analysis
- 10.1. Veterinary Pain Management Market, Regional Market Snapshot
- 10.2. North America Veterinary Pain Management Market
- 10.2.1. U.S. Veterinary Pain Management Market
- 10.2.1.1. Product breakdown estimates & forecasts, 2019-2029
- 10.2.1.2. Indication breakdown estimates & forecasts, 2019-2029
- 10.2.1.3. Animal Type breakdown estimates & forecasts, 2019-2029
- 10.2.1.4. End User breakdown estimates & forecasts, 2019-2029
- 10.2.2. Canada Veterinary Pain Management Market
- 10.3. Europe Veterinary Pain Management Market Snapshot
- 10.3.1. U.K. Veterinary Pain Management Market
- 10.3.2. Germany Veterinary Pain Management Market
- 10.3.3. France Veterinary Pain Management Market
- 10.3.4. Spain Veterinary Pain Management Market
- 10.3.5. Italy Veterinary Pain Management Market
- 10.3.6. Rest of Europe Veterinary Pain Management Market
- 10.4. Asia-Pacific Veterinary Pain Management Market Snapshot
- 10.4.1. China Veterinary Pain Management Market
- 10.4.2. India Veterinary Pain Management Market
- 10.4.3. Japan Veterinary Pain Management Market
- 10.4.4. Australia Veterinary Pain Management Market
- 10.4.5. South Korea Veterinary Pain Management Market
- 10.4.6. Rest of Asia Pacific Veterinary Pain Management Market
- 10.5. Latin America Veterinary Pain Management Market Snapshot
- 10.5.1. Brazil Veterinary Pain Management Market
- 10.5.2. Mexico Veterinary Pain Management Market
- 10.6. Rest of The World Veterinary Pain Management Market
Chapter 11. Competitive Intelligence
- 11.1. Top Market Strategies
- 11.2. Company Profiles
- 11.2.1. Boehringer Ingelheim International GmbH
- 11.2.1.1. Key Information
- 11.2.1.2. Overview
- 11.2.1.3. Financial (Subject to Data Availability)
- 11.2.1.4. Product Summary
- 11.2.1.5. Recent Developments
- 11.2.2. Zoetis Inc.
- 11.2.3. Elanco Animal Health Incorporated
- 11.2.4. Merck & Co., Inc.
- 11.2.5. Dechra Pharmaceuticals
- 11.2.6. Vetoquinol
- 11.2.7. SeQuent Scientific Limited
- 11.2.8. Norbrook Laboratories Limited
- 11.2.9. Ceva Sante Animale
- 11.2.10. Chanelle Pharma
Chapter 12. Research Process
- 12.1. Research Process
- 12.1.1. Data Mining
- 12.1.2. Analysis
- 12.1.3. Market Estimation
- 12.1.4. Validation
- 12.1.5. Publishing
- 12.2. Research Attributes
- 12.3. Research Assumption